Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris
Public ClinicalTrials.gov record NCT00688064. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Associated With Doxycycline Hyclate 100 mg Tablets Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Vehicle Gel Associated With Doxycycline Hyclate 100 mg Tablets in the Treatment of Severe Acne Vulgaris.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% / Benzoyl Peroxide (quoted as BPO) 2.5% Gel associated with Doxycycline Hyclate 100 mg Tablets compared to Adapalene 0.1% /Benzoyl Peroxide 2.5% Vehicle Gel associated with Doxycycline Hyclate 100 mg Tablets, in the treatment of severe acne vulgaris. The safety of the two treatment regimens will also be evaluated.
Study identification
- NCT ID
- NCT00688064
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 459 participants
Conditions and interventions
Conditions
Interventions
- Adapalene BPO Gel associated with Doxycyline Hyclate Drug
- Vehicle Gel associated with Doxycycline Hyclate Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 35 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2008 (Type not available)
- Primary completion
- Feb 2009 (Actual)
- Completion
- Feb 2009 (Actual)
- Last update posted
- Feb 18, 2021
2008 – 2009
United States locations
- U.S. sites
- 28
- U.S. states
- 18
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site | Oceanside | California | — | — |
| Galderma Investigational Site | San Diego | California | — | — |
| Galderma Investigational Site | Denver | Colorado | — | — |
| Galderma Investigational Site | Longmont | Colorado | — | — |
| Galderma Investigational Site | Miami | Florida | — | — |
| Galderma Investigational Site | Snellville | Georgia | — | — |
| Galderma Investigational Site | Chicago | Illinois | — | — |
| Galderma Investigational Site | Evansville | Indiana | — | — |
| Galderma Investigational Site | Overland Park | Kansas | — | — |
| Galderma Investigational Site | Louisville | Kentucky | — | — |
| Galderma Investigational Site | Detroit | Michigan | — | — |
| Galderma Investigational Site | Fort Gratiot | Michigan | — | — |
| Galderma Investigational Site | Fridley | Minnesota | — | — |
| Galderma Investigational Site | Omaha | Nebraska | — | — |
| Galderma Investigational Site | Albuquerque | New Mexico | — | — |
| Galderma Investigational Site | Stony Brook | New York | — | — |
| Galderma Investigational Site | Winston-Salem | North Carolina | — | — |
| Galderma Investigational Site | Warren | Ohio | — | — |
| Galderma Investigational Site | Hazleton | Pennsylvania | — | — |
| Galderma Investigational Site | Hershey | Pennsylvania | — | — |
| Galderma Investigational Site | Simpsonville | South Carolina | — | — |
| Galderma Investigational Site | Arlington | Texas | — | — |
| Galderma Investigational Site | Austin | Texas | — | — |
| Galderma Investigational Site | College Station | Texas | — | — |
| Galderma Investigational Site | Houston | Texas | — | — |
| Galderma Investigational Site | Lubbock | Texas | — | — |
| Galderma Investigational Site | San Antonio | Texas | — | — |
| Galderma Investigational Site | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00688064, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00688064 live on ClinicalTrials.gov.